LINCOLN- Two bills, LB142 introduced by Sen. Tom Briese and LB779 introduced by Sen. Eliot Bostar, would cap the price of insulin to varying amounts in Nebraska. Sen. Breise's bill would cap the price of the life-saving drug to $100 per patient for a 30-day supply, while Sen. Bostar's bill would cap the price at $35 for the same amount.

Bostar outlined the fact that 9.6% of Nebraska adults are diagnosed with diabetes, and emphasized that the rising cost of medications is making it difficult for patients to purchase the medications they require. Similarly, Briese stated that some Nebraskans are being asked to pay more than $1,000 a month for a 30-day supply.

Last year, the federal government capped the price of insulin at $35 per month for Medicare beneficiaries, and roughly 20 states have established their own caps on the drug. Sen. Briese estimated that the average state-ordained cap was likely between $50-75, and said he "would submit that we...do the same thing."

For the full article click HERE